
<div class="notifyMain">
  <div class="notifyMain-inner">
    <div class="notifyMain-content">
      <h2 class="notifyMain-heading">Indication and Limitation of use</h2>
      <div class="notifyMain-copy">
        <p><span>Vectibix<sup>&reg; </sup>is indicated for the treatment of patients with wild-type <em>RAS </em>(defined as wild-type in both <em>KRAS </em>and <em>NRAS </em>
            <as>determined by an FDA-approved test for this use) metastatic colorectal cancer (mCRC): </as></span><span>as first-line therapy in combination with FOLFOX, and as monotherapy following disease progression after prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy. </span></p>
        <p>Limitation of Use: Vectibix<sup>&reg; </sup>is not indicated for the treatment of patients with <em>RAS</em>â€‘mutant mCRC or for whom <em>RAS</em> mutation status is unknown.</p>
      </div>
    </div>
    <div class="notifyMain-close"></div>
  </div>
</div>